Reference
Carl-Fredrik Burman, Martin Forster, Sebastian Jobjörnsson, and Paolo Pertile (University of Verona), “Late-Stage Pharmaceutical R&D for Rare Diseases under Two-Stage Regulation”, 16th European Health Economics Workshop, Toulouse, France, May 28–29, 2015.
See also
Published in
16th European Health Economics Workshop, Toulouse, France, May 28–29, 2015